Comorbid substance use disorders in schizophrenia: A latent class approach

被引:22
|
作者
Kerner, Befit [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Schizophrenia; Substance use disorders; Family history of psychosis; Dependence; Disease course; Major depressive disorder; AGE-OF-ONSET; CANNABIS USE DISORDERS; ALCOHOL-USE DISORDERS; FAMILY-HISTORY; GENETIC LIABILITY; DUAL DIAGNOSIS; RISK-FACTORS; GENOME-WIDE; DRUG-ABUSE; FOLLOW-UP;
D O I
10.1016/j.psychres.2014.12.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Schizophrenia is a complex psychiatric disorder with a characteristic disease course and heterogeneous etiology. While substance use disorders and a family history of psychosis have individually been identified as risk factors for schizophrenia, it is less well understood if and how these factors are related. To address this deficiency, we examined the relationship between substance use disorders and family history of psychosis in a sample of 1219 unrelated patients with schizophrenia. The lifetime rate of substance use disorders in this sample was 50%, and 30% had a family history of psychosis. Latent class mixture modeling identified three distinct patient subgroups: (1) individuals with low probability of substance use disorders; (2) patients with drug and alcohol abuse, but no symptoms of dependence; and (3) patients with substance dependence. Substance use was related to being male, to a more severe disease course, and more acute symptoms at assessment, but not to an earlier age of onset of schizophrenia or a specific pattern of positive and negative symptoms. Furthermore, substance use in schizophrenia was not related to a family history of psychosis. The results suggest that substance use in schizophrenia is an independent risk factor for disease severity and onset. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 50 条
  • [41] Treatment of Comorbid Substance Use Disorders and ADHD in Youth
    Carrellas N.
    Wilens T.E.
    Anselmo R.
    [J]. Current Treatment Options in Psychiatry, 2016, 3 (1) : 15 - 27
  • [42] LATENT CLASS ANALYSIS OF STUDENT SUBSTANCE USE
    Harrison, W. J.
    Montana, C.
    Bewick, B. M.
    Gilthorpe, M. S.
    West, R. M.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A189 - A189
  • [43] Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders:: A review
    Bechdolf, A
    Pohlmann, B
    Geyer, C
    Ferber, C
    Klosterkötter, J
    Gouzoulis-Mayfrank, E
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2005, 73 (12) : 728 - 735
  • [44] Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data
    Patel, Rashmi
    Chan, Kelly M. Y.
    Palmer, Emily O. C.
    Valko, Matthew
    Guruswamy, Guruprabha
    Ker, Sheryl
    Batra, Gunjan
    Renteria, Miguel E.
    Kollins, Scott H.
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 260 : 191 - 197
  • [45] Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders:: an open-label trial
    Potvin, Stephane
    Stip, Emmanuel
    Lipp, Olivier
    Elie, Robert
    Mancini-Marie, Adham
    Demers, Marie-France
    Roy, Marc-Andre
    Bouchard, Roch-Hugo
    Gendron, Alain
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (07) : 1277 - 1285
  • [46] Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review
    Adan, Ana
    Arredondo, Arantxa Y.
    del Mar Capella, Maria
    Prat, Gemma
    Forero, Diego A.
    Francisco Navarro, Jose
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 75 : 361 - 377
  • [47] Latent cyclothymia as precursor of substance use disorders
    Rovai, L.
    Maremmani, A. G. I.
    Bacciardi, S.
    Massimetti, E.
    Pallucchini, A.
    Maremmani, I.
    [J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2016, 18 (03) : 32 - 32
  • [48] The effect of comorbid substance use disorders on treatment outcome for anxiety disorders
    McEvoy, Peter M.
    Shand, Fiona
    [J]. JOURNAL OF ANXIETY DISORDERS, 2008, 22 (06) : 1087 - 1098
  • [49] Comorbid substance use reduces the health care contacts of suicide attempters with schizophrenia spectrum or mood disorders
    Suominen, KH
    Isometsä, ET
    Lönnqvist, JK
    [J]. SCHIZOPHRENIA BULLETIN, 2002, 28 (04) : 637 - 647
  • [50] Psychotic disorders and comorbid substance use disorders: Clinical and therapeutic problems
    Gouzoulis-Mayfrank E.
    [J]. Forensische Psychiatrie, Psychologie, Kriminologie, 2016, 10 (1) : 14 - 20